|Day Low/High||2.79 / 2.89|
|52 Wk Low/High||2.48 / 4.99|
Intra-Cellular Therapies, Organovo Holdings and Acorda Therapeutics were among the biotech stock movers in premarket trading on Monday.
Organovo, Endo and Omeros were among the biotech stock moves in premarket trading on Thursday.
The company's shares were up 24% ahead of market's open on an FDA approval.
Organovo also celebrates positive review of Organovo's 3D bioprinted human liver tissue from industry leaders
The companies inked a $250 million deal on Friday that could be worth up to $2 billion, thanks to milestone payments.
Pacira Pharmaceuticals, Clearside Biomedical and Organovo Holdings are among the premarket biotech movers on Wednesday.
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.
Investors in Organovo Holdings Inc saw new options begin trading this week, for the August 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Results demonstrate clinical promise for bioprinted tissues
The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 4,796,096 share decrease in total short interest for Organovo Holdings Inc , to 10,067,667, a decrease of 32.27% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Investors in Organovo Holdings Inc saw new options become available today, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ONVO options chain for the new December 16th contracts and identified the following call contract of particular interest.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Organovo Holdings Inc , where a total volume of 2,908 contracts has been traded thus far today, a contract volume which is representative of approximately 290,800 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 43.2% of ONVO's average daily trading volume over the past month, of 673,160 shares.
Organovo (ONVO) said on Thursday that it would sell 9 million shares of common stock at $2.75 per share in a public offering.